- Report
- July 2024
- 115 Pages
Global
From €4541EUR$4,750USD£3,802GBP
- Report
- July 2020
- 164 Pages
Global
From €1183EUR$1,238USD£990GBP
€2366EUR$2,475USD£1,981GBP
- Report
- January 2023
- 44 Pages
Global
From €1434EUR$1,500USD£1,200GBP
- Report
- February 2018
- 135 Pages
Global
From €4780EUR$5,000USD£4,002GBP
The Drug Pricing market is an important part of Pharmacoeconomics, which is the study of the cost-effectiveness of pharmaceuticals. It involves the analysis of the cost of drugs, the value of their therapeutic benefits, and the impact of their pricing on the healthcare system. Drug pricing is a complex process that involves multiple stakeholders, including pharmaceutical companies, health insurers, and government agencies. It is also influenced by factors such as the availability of generic drugs, the cost of research and development, and the cost of production.
The Drug Pricing market is highly competitive, with companies competing to offer the best prices and the most effective drugs. Companies in the market include Pfizer, Merck, Novartis, GlaxoSmithKline, Sanofi, Johnson & Johnson, and AstraZeneca. Show Less Read more